Identification of a new exon 2-skipped TNFR1 transcript: Regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene

Annals of the Rheumatic Diseases

Volumn 73, Issue 1, 2014, Pages 290-297

  Rittore, Cécile ^a,b   Sanchez, Elodie ^a   Soler, Stephan ^a,b   Barat Houari, Mouna ^b   Albers, Marieke ^c   Obici, Laura ^d   McDermott, Michael F ^e   Touitou, Isabelle ^a,b,f   Grandemange, Sylvie ^a,b  

^a HÔPITAL SAINT ELOI   (France)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e UNIVERSITY OF LEEDS   (United Kingdom)

^f UNIV MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR 1;

ALTERNATIVE RNA SPLICING; ARTICLE; CELL STRAIN HEK293; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO; EXON SKIPPING; GENE EXPRESSION; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TNFRSF1A GENE; TRANSCRIPTION REGULATION; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED PERIODIC SYNDROME;

ALTERNATIVE SPLICING; AUTOINFLAMMATORY DISEASE; RECURRENT FEVER; TNFR1 TRANSCRIPT; TRAPS;

ADENOCARCINOMA; ALTERNATIVE SPLICING; COLONIC NEOPLASMS; EXONS; GENE EXPRESSION REGULATION; GENETIC COMPLEMENTATION TEST; HAPLOTYPES; HEK293 CELLS; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; INTRONS; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I;

EID: 84889659698     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-203023     Document Type: Article

References (37)

1. Loetscher H, Pan YC, Lahm HW, et al. Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor. Cell 1990;61:351-9.
2. Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol 2001;11:372-7. (Pubitemid 32900529)
3. Lobito AA, Gabriel TL, Medema JP, et al. Disease causing mutations in the TNF and TNFR superfamilies: Focus on molecular mechanisms driving disease. Trends Mol Med 2011;17:494-505.
4. McDermott MF, Aksentijevich I, Galon J, et al. Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 1999;97:133-44. (Pubitemid 29165896)
5. Milhavet F, Cuisset L, Hoffman HM, et al. The infevers autoinflammatory mutation online registry: update with new genes and functions. Hum Mutat 2008;29:803-8. (Pubitemid 351794131)
6. McDermott MF, Aksentijevich I. The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2002;2:511-16. (Pubitemid 36105814)
7. Aganna E, Hammond L, Hawkins PN, et al. Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum 2003;48:2632-44. (Pubitemid 37129441)
8. Borghini S, Fiore M, Di Duca M, et al. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene. J Rheumatol 2011;38:1378-84.
9. Aksentijevich I, Kastner DL. Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol 2011;7:469-78.
10. Bachetti T, Chiesa S, Castagnola P, et al. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS). Ann Rheum Dis 2013;72:1044-52.
11. Bulua AC, Simon A, Maddipati R, et al. Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 2011;208:519-33.
12. Dickie LJ, Aziz AM, Savic S, et al. Involvement of X-box binding protein 1 and reactive oxygen species pathways in the pathogenesis of tumour necrosis factor receptor-associated periodic syndrome. Ann Rheum Dis 2012;71:2035-43.
13. Masters SL, Simon A, Aksentijevich I, et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (&z.ast;). Annu Rev Immunol 2009;27:621-68.
14. Matsukura H, Ikeda S, Yoshimura N, et al. Genetic polymorphisms of tumour necrosis factor receptor superfamily 1A and 1B affect responses to infliximab in Japanese patients with Crohn's disease. Aliment Pharmacol Ther 2008;27:765-70. (Pubitemid 351490066)
15. Sainz J, Salas-Alvarado I, Lopez-Fernandez E, et al. TNFR1 mRNA expression level and TNFR1 gene polymorphisms are predictive markers for susceptibility to develop invasive pulmonary aspergillosis. Int J Immunopathol Pharmacol 2010;23:423-36.
16. Stanke F, Becker T, Cuppens H, et al. The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet 2006;119:331-43.
17. Montgomery SB, Dermitzakis ET. The resolution of the genetics of gene expression. Hum Mol Genet 2009;18(R2):R211-15.
18. Grandemange S, Soler S, Touitou I. Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay. Hum Mol Genet 2009; 18:4746-55.
19. Kishore S, Khanna A, Stamm S. Rapid generation of splicing reporters with pSpliceExpress. Gene 2008;427:104-10.
20. Waschke KA, Villani AC, Vermeire S, et al. Tumor necrosis factor receptor gene polymorphisms in Crohn's disease: association with clinical phenotypes. Am J Gastroenterol 2005;100:1126-33. (Pubitemid 40769052)
21. Shukla S, Oberdoerffer S. Co-transcriptional regulation of alternative pre-mRNA splicing. Biochim Biophys Acta 2012;1819:673-83.
22. Chen M, Manley JL. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009;10:741-54.
23. Aksentijevich I, Galon J, Soares M, et al. The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 2001;69:301-14. (Pubitemid 32695203)
24. Ravet N, Rouaghe S, Dode C, et al. Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 2006;65:1158-62. (Pubitemid 44277389)
25. Seitz C, Muller P, Krieg RC, et al. A novel p75TNF receptor isoform mediating NFkappa B activation. J Biol Chem 2001;276:19390-5.
26. Lainez B, Fernandez-Real JM, Romero X, et al. Identification and characterization of a novel spliced variant that encodes human soluble tumor necrosis factor receptor 2. Int Immunol 2004;16:169-77. (Pubitemid 38054638)
27. Gregory AP, Dendrou CA, Attfield KE, et al. TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. Nature 2012;488:508-11.
28. Kornblihtt AR, de la Mata M, Fededa JP, et al. Multiple links between transcription and splicing. RNA 2004;10:1489-98. (Pubitemid 39288183)
29. Montes M, Becerra S, Sanchez-Alvarez M, et al. Functional coupling of transcription and splicing. Gene 2012;501:104-17.
30. Tazi J, Bakkour N, Stamm S. Alternative splicing and disease. Biochim Biophys Acta 2009;1792:14-26.
31. Cramer P, Caceres JF, Cazalla D, et al. Coupling of transcription with alternative splicing: RNA pol II promoters modulate SF2/ASF and 9G8 effects on an exonic splicing enhancer. Mol Cell 1999;4:251-8. (Pubitemid 29456893)
32. Pagani F, Stuani C, Zuccato E, et al. Promoter architecture modulates CFTR exon 9 skipping. J Biol Chem 2003;278:1511-17. (Pubitemid 36801378)
33. Cramer P, Pesce CG, Baralle FE, et al. Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci USA 1997;94: 11456-60. (Pubitemid 27451020)
34. De Jager PL, Jia X, Wang J, et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009;41:776-82.
35. Amoura Z, Dode C, Hue S, et al. Association of the R92Q TNFRSF1A mutation and extracranial deep vein thrombosis in patients with Behcet's disease. Arthritis Rheum 2005;52:608-11. (Pubitemid 40216326)
36. Dieude P, Osorio J, Petit-Teixeira E, et al. A TNFR1 genotype with a protective role in familial rheumatoid arthritis. Arthritis Rheum 2004;50:413-19. (Pubitemid 38198825)
37. Kumpfel T, Hohlfeld R. Multiple sclerosis. TNFRSF1A, TRAPS and multiple sclerosis. Nat Rev Neurol 2009;5:528-9.